BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25464974)

  • 1. Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors.
    Montgomery JI; Smith JF; Tomaras AP; Zaniewski R; McPherson CJ; McAllister LA; Hartman-Neumann S; Arcari JT; Lescoe M; Gutierrez J; Yuan Y; Limberakis C; Miller AA
    J Antibiot (Tokyo); 2015 Jun; 68(6):361-7. PubMed ID: 25464974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of Chemical Compounds that Inhibit Leucyl-tRNA Synthetase from
    Zamacona R; Chavero PN; Medellin E; Hu Y; Hughes CA; Quach N; Keniry M; Bullard JM
    Curr Drug Discov Technol; 2020; 17(1):119-130. PubMed ID: 30088448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl-tRNA Synthetase from
    Balboa S; Hu Y; Dean FB; Bullard JM
    SLAS Discov; 2020 Jan; 25(1):57-69. PubMed ID: 31498734
    [No Abstract]   [Full Text] [Related]  

  • 4. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.
    Hernandez V; Crépin T; Palencia A; Cusack S; Akama T; Baker SJ; Bu W; Feng L; Freund YR; Liu L; Meewan M; Mohan M; Mao W; Rock FL; Sexton H; Sheoran A; Zhang Y; Zhang YK; Zhou Y; Nieman JA; Anugula MR; Keramane el M; Savariraj K; Reddy DS; Sharma R; Subedi R; Singh R; O'Leary A; Simon NL; De Marsh PL; Mushtaq S; Warner M; Livermore DM; Alley MR; Plattner JJ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1394-403. PubMed ID: 23295920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of ATP-Competitive Inhibitors of tRNAIle Lysidine Synthetase (TilS) by High-Throughput Screening.
    Shapiro AB; Plant H; Walsh J; Sylvester M; Hu J; Gao N; Livchak S; Tentarelli S; Thresher J
    J Biomol Screen; 2014 Sep; 19(8):1137-46. PubMed ID: 24820111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new set of assays for the discovery of aminoacyl-tRNA synthetase inhibitors.
    Saint-Léger A; Ribas de Pouplana L
    Methods; 2017 Jan; 113():34-45. PubMed ID: 27989759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaminyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization, structure, and development as a screening platform.
    Escamilla Y; Hughes CA; Abendroth J; Dranow DM; Balboa S; Dean FB; Bullard JM
    Protein Sci; 2020 Apr; 29(4):905-918. PubMed ID: 31833153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to an amino acid antibiotic that targets translation.
    Ataide SF; Wilson SN; Dang S; Rogers TE; Roy B; Banerjee R; Henkin TM; Ibba M
    ACS Chem Biol; 2007 Dec; 2(12):819-27. PubMed ID: 18154269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria.
    Moreau RJ; Skepper CK; Appleton BA; Blechschmidt A; Balibar CJ; Benton BM; Drumm JE; Feng BY; Geng M; Li C; Lindvall MK; Lingel A; Lu Y; Mamo M; Mergo W; Polyakov V; Smith TM; Takeoka K; Uehara K; Wang L; Wei JR; Weiss AH; Xie L; Xu W; Zhang Q; de Vicente J
    J Med Chem; 2018 Apr; 61(8):3309-3324. PubMed ID: 29498517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis.
    Ravishankar S; Ambady A; Swetha RG; Anbarasu A; Ramaiah S; Sambandamurthy VK
    PLoS One; 2016; 11(1):e0147188. PubMed ID: 26794499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
    Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
    Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
    Wei W; Liu Q; Li ZZ; Shi WK; Fu X; Liu J; Zhu X; Wang XC; Xu N; Li TF; Jiang FR; Xiao ZP; Zhu HL
    Eur J Med Chem; 2017 Jun; 133():62-68. PubMed ID: 28380394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.
    Hinsberger S; Hüsecken K; Groh M; Negri M; Haupenthal J; Hartmann RW
    J Med Chem; 2013 Nov; 56(21):8332-8. PubMed ID: 24112046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-based methods for the discovery of inhibitors modulating lysyl-tRNA synthetase and laminin receptor interaction.
    Cho HY; Kim S; Jeon YH
    Methods; 2017 Jan; 113():56-63. PubMed ID: 27789335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
    Alharthi S; Ziora ZM; Moyle PM
    Bioorg Med Chem; 2021 Dec; 52():116527. PubMed ID: 34839159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and structure determination of prolyl-tRNA synthetase from Pseudomonas aeruginosa and development as a screening platform.
    Pena N; Dranow DM; Hu Y; Escamilla Y; Bullard JM
    Protein Sci; 2019 Apr; 28(4):727-737. PubMed ID: 30666738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
    Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity.
    Skepper CK; Moreau RJ; Appleton BA; Benton BM; Drumm JE; Feng BY; Geng M; Hu C; Li C; Lingel A; Lu Y; Mamo M; Mergo W; Mostafavi M; Rath CM; Steffek M; Takeoka KT; Uehara K; Wang L; Wei JR; Xie L; Xu W; Zhang Q; de Vicente J
    J Med Chem; 2018 Apr; 61(8):3325-3349. PubMed ID: 29551072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.